Patent ID: 8299056

Claim:
A compound of formula (I): or pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein: R 1 is a substituted or unsubstituted aryl, or a substituted or unsubstituted heterocyclyl; R 2 is a substituted C 1-8 alkyl, an unsubstituted non-aromatic cycloalkyl, an unsubstituted non-aromatic heterocyclylalkyl, an unsubstituted aralkyl, —NR 3 R 4 , —OR 3 , —C(═O)R 5 , —C(═O)NR 3 R 4 , —NHC(═O)R 3 , —(CH 2 ) 0-2 CR 6 (OR 3 )R 4 , or an unsubstituted heterocyclyl selected from azetidinyl, pyrrolidyl, morpholinyl, 1,2,3,6-tetrahydropyridyl, isoxazolyl, imidazolyl, indazolyl, benzimidazolyl, benzisoxazolyl, benzo[d]oxazolyl, isoindolin-1-onyl, isoquinolinyl, or quinolyl; R 3 and R 4 are at each occurrence independently —H, a substituted or unsubstituted C 1-8 alkyl, a substituted or unsubstituted aryl, a substituted or unsubstituted heteroaryl, a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted heterocyclyl, a substituted or unsubstituted aralkyl, or a substituted or unsubstituted heterocyclylalkyl; R 5 is substituted or unsubstituted C 1-8 alkyl, a substituted or unsubstituted aryl, a substituted or unsubstituted heteroaryl, a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted heterocyclyl, a substituted or unsubstituted aralkyl, or a substituted or unsubstituted heterocyclylalkyl; and R 6 is —H, or a substituted or unsubstituted C 1-8 alkyl, or together with R 4 and the atoms to which they are attached form a substituted or unsubstituted heterocyclyl; provided the compound is not N 5 -cyclopentyl-N 2 -(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-[1,2,4]triazolo[1,5-a]pyridine-2,5-diamine.